Lupin Pharmaceuticals Inc. is recalling 4,608 bottles of Cefixime for Oral Suspension (100mg/5mL). This prescription antibiotic is used to treat various bacterial infections. The recall was initiated because the product failed to meet quality specifications for impurities or degradation, which could affect the medication's effectiveness or safety. No injuries or illnesses have been reported to date.
Using medication that has degraded or contains unexpected impurities can mean the treatment is less effective or contains substances that should not be there. This could result in a bacterial infection failing to clear as expected or causing unforeseen side effects.
You have 2 options:
Manufactured for Lupin Pharmaceuticals, Inc. by Lupin Limited in India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.